2.1 DSM-5-TR Substance Use Disorder Diagnostic Criteria & Severity Classification
Key Takeaways
- The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) integrates substance abuse and substance dependence into a single continuum: Substance Use Disorder (SUD).
- Diagnostic criteria comprise 11 specific symptoms categorized across 4 functional domains: Impaired Control (1–4), Social Impairment (5–7), Risky Use (8–9), and Pharmacological Criteria (10–11).
- SUD severity is explicitly classified based on the criterion count met within a 12-month period: Mild (2–3 criteria), Moderate (4–5 criteria), and Severe (6 or more criteria).
- Tolerance and withdrawal criteria (10 and 11) do NOT count toward a SUD diagnosis when the substance is taken solely under appropriate, supervised medical treatment (e.g., prescribed opioids or sedative-hypnotics).
- Remission specifiers are strictly defined: Early Remission requires meeting zero SUD criteria (except craving) for ≥3 but <12 months; Sustained Remission requires meeting zero criteria (except craving) for ≥12 months.
DSM-5-TR Substance Use Disorder Diagnostic Criteria & Severity Classification
Overview of the DSM-5-TR Diagnostic Framework
The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) represents the gold standard for clinical classification of addictive disorders. A major conceptual evolution in modern addiction medicine was the consolidation of the previously distinct categories of substance abuse and substance dependence into a unified, dimensional diagnosis: Substance Use Disorder (SUD).
Substance Use Disorder is defined as a cluster of cognitive, behavioral, and physiological symptoms indicating that the individual continues using the substance despite significant substance-related problems. The DSM-5-TR provides specific diagnostic criteria for ten distinct substance classes: alcohol, cannabis, phencyclidine (PCP), other hallucinogens, inhalants, opioids, sedatives/hypnotics/anxiolytics, stimulants (amphetamines, cocaine), tobacco, and other/unknown substances. While caffeine is recognized under caffeine intoxication and withdrawal, it is not formally classified as a substance use disorder in the current manual.
For Certified Addictions Registered Nurses (CARN), evaluating patients against these criteria requires a thorough clinical interview, collateral verification, physical assessment, and objective laboratory screening. The nurse must systematically evaluate the presence of each criterion over a 12-month observation window.
The 11 Diagnostic Criteria & 4 Functional Domains
The 11 diagnostic criteria are logically organized into four core functional domains. Understanding these domains enables the addictions nurse to recognize behavioral patterns and construct targeted nursing care plans.
| Functional Domain | Criteria Numbers | Specific Diagnostic Criterion Description |
|---|---|---|
| Impaired Control | Criterion 1 | Substance taken in larger amounts or over a longer period than intended. |
| Criterion 2 | Persistent desire or unsuccessful efforts to cut down or control substance use. | |
| Criterion 3 | Great deal of time spent in activities necessary to obtain, use, or recover from substance effects. | |
| Criterion 4 | Craving, or a strong desire or urge to use the substance. | |
| Social Impairment | Criterion 5 | Recurrent substance use resulting in failure to fulfill major role obligations at work, school, or home. |
| Criterion 6 | Continued substance use despite persistent or recurrent social or interpersonal problems caused or exacerbated by use. | |
| Criterion 7 | Important social, occupational, or recreational activities given up or reduced because of use. | |
| Risky Use | Criterion 8 | Recurrent substance use in situations in which it is physically hazardous (e.g., driving while intoxicated). |
| Criterion 9 | Substance use continued despite knowledge of having a persistent physical or psychological problem likely caused or exacerbated by use. | |
| Pharmacological | Criterion 10 | Tolerance: Need for markedly increased amounts to achieve intoxication, or markedly diminished effect with continued use of same amount. |
| Criterion 11 | Withdrawal: Characteristic withdrawal syndrome manifested, or substance taken to relieve or avoid withdrawal symptoms. |
Domain 1: Impaired Control (Criteria 1–4)
Impaired control reflects neurobiological alterations in the brain's reward and executive control circuitry. Patients frequently describe spending excessive hours obtaining illicit substances or recovering from severe binges. Criterion 4 (Craving) was added in DSM-5 to capture intense conditioning cues that trigger compulsive drug-seeking behavior. Craving is often measured clinically using visual analog scales and serves as a primary target for pharmacological anti-craving therapies (e.g., naltrexone, acamprosate).
Domain 2: Social Impairment (Criteria 5–7)
Social impairment evaluates how substance use disrupts functional roles and human relationships. Nurses assess work absenteeism, academic failure, neglect of child-care responsibilities, and ongoing domestic disputes. The loss of valued pro-social activities (Criterion 7) highlights the progressive narrowing of behavioral repertoires characteristic of advancing addiction.
Domain 3: Risky Use (Criteria 8–9)
Risky use examines failure to abstain despite immediate physical danger or documented medical/psychiatric harm. Criterion 8 encompasses driving under the influence, operating heavy machinery, or risky sexual practices while intoxicated. Criterion 9 highlights persistent use despite diagnosed conditions such as alcoholic hepatitis, opioid-induced respiratory failure, or cocaine-associated cardiomyopathy.
Domain 4: Pharmacological Criteria (Criteria 10–11)
Pharmacological criteria reflect neuroadaptation. Tolerance develops as neuroreceptors down-regulate or metabolic clearance accelerates. Withdrawal represents the physiological rebound when blood or tissue concentrations decline.
Critical Nursing Exception Rule: Symptoms of tolerance and withdrawal that develop during appropriate medical treatment with prescribed medications (e.g., analgesics for chronic pain, sedative-hypnotics for insomnia, or stimulants for ADHD) are NOT counted toward a diagnosis of Substance Use Disorder. This rule prevents improper stigmatization of chronic pain patients adhering to legitimate therapeutic regimens.
Severity Stratification & Clinical Application
The DSM-5-TR establishes a transparent severity scale based strictly on the total number of diagnostic criteria endorsed within a 12-month period. Severity stratification dictates the appropriate level of care under the American Society of Addiction Medicine (ASAM) criteria.
DSM-5-TR Severity Continuum:
0 - 1 Criterion --> No SUD Diagnosis (Sub-clinical / At-Risk)
2 - 3 Criteria --> MILD Substance Use Disorder
4 - 5 Criteria --> MODERATE Substance Use Disorder
6+ Criteria --> SEVERE Substance Use Disorder
- Mild SUD (2–3 criteria): Corresponds typically to early-stage illness or outpatient intervention (ASAM Level 1.0). Interventions focus on Brief Intervention, motivational interviewing, and outpatient counseling.
- Moderate SUD (4–5 criteria): Warrants structured outpatient programs, intensive outpatient programs (IOP, ASAM Level 2.1), or partial hospitalization (ASAM Level 2.5), often incorporating pharmacotherapy.
- Severe SUD (6+ criteria): Represents advanced addiction frequently complicated by physical dependence, severe psychosocial instability, or medical comorbidity. Requires residential treatment (ASAM Level 3.5/3.7) or medically monitored inpatient detoxification (ASAM Level 4.0).
Remission Specifiers & Contextual Modifiers
Nurses must document accurate remission specifiers to reflect a patient's recovery trajectory:
- Early Remission: Full criteria for Substance Use Disorder were previously met, but zero criteria have been met for at least 3 months but less than 12 months (with the sole exception of Criterion 4: Craving).
- Sustained Remission: Full criteria for Substance Use Disorder were previously met, but zero criteria have been met for 12 months or longer (with the sole exception of Criterion 4: Craving).
- In a Controlled Environment: Applied if the individual is in an environment where access to substance use is strictly restricted (e.g., locked residential treatment units, penal institutions, or supervised long-term recovery communities).
- On Maintenance Therapy: Applied when the individual is taking a prescribed agonist or partial agonist medication (e.g., methadone or buprenorphine maintenance for Opioid Use Disorder) or nicotine replacement therapy, and no criteria for that substance class are met (except tolerance/withdrawal to the maintenance agent).
Nursing Assessment Workflow
When evaluating a patient for SUD, the CARN nurse follows a structured assessment workflow:
- Establish Therapeutic Rapport: Use non-stigmatizing, person-first language (e.g., "person with an opioid use disorder" rather than "addict").
- Systematic Review of Systems & Behavioral Inventory: Screen each of the 11 criteria using validated open-ended questions.
- Distinguish Prescribed vs. Non-Prescribed Use: Verify medical records, prescription drug monitoring program (PDMP) data, and prescribing indications.
- Calculate Severity Score: Sum the positive criteria met over the past 12 months.
- Identify Remission & Environment Specifiers: Confirm exact duration of abstinence and current environmental restrictions.
A 42-year-old patient presents for an addiction nursing assessment. Over the past 12 months, the patient reports taking larger quantities of alcohol than intended, multiple failed attempts to cut down, persistent craving for alcohol, failure to fulfill major work deadlines, and continued drinking despite knowing it worsens their hypertension. What is the correct DSM-5-TR diagnostic severity classification for this patient's Alcohol Use Disorder?
A patient with chronic cancer pain has been taking prescribed oxycodone daily under strict medical supervision for 8 months. The patient experiences increased pain control needs requiring dose titration (tolerance) and experiences diaphoresis and tachycardia if a dose is delayed (withdrawal). The patient displays no impaired control, social impairment, or risky use behaviors. How should the CARN nurse interpret these findings under DSM-5-TR guidelines?
A nurse is reviewing the medical record of a patient in recovery from Severe Cocaine Use Disorder. The patient has met zero diagnostic criteria for cocaine use disorder (with the exception of occasional craving) for the past 7 months while living in a community recovery residence. Which DSM-5-TR remission specifier should the nurse document?